Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Amy C. Brown, Janet Onopa, Peter Holck, Pakieli Kaufusi, Derek Kabasawa, Winston J. Craig, Klaus Dragull, Arieh M. Levine & Jonathan D. Baker. (2007) Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii. Clinical Toxicology 45:5, pages 549-556.
Read now
Read now
Articles from other publishers (48)
Jian Xiang Yang. (2023) A New Kavalactone Dimer from Piper methysticum. Chemistry of Natural Compounds 59:3, pages 420-423.
Crossref
Crossref
Deborah R. Simkin, Shayna Swick, Krishna S. Taneja & Noshene Ranjbar. (2023) Complementary and Integrative Medicine for Anxiety in Children, Adolescents, and Young Adults. Child and Adolescent Psychiatric Clinics of North America 32:2, pages 193-216.
Crossref
Crossref
Lydia Sandrah Kaforau, Gizachew A. Tessema, Jonine Jancey, Hugo Bugoro & Gavin Pereira. (2023) Prevalence and Factors Associated With Low Birth Weight in the Solomon Islands: Evidence From the 2015 Solomon Islands Demographic and Health Survey data. Asia Pacific Journal of Public Health 35:2-3, pages 136-144.
Crossref
Crossref
Deana Goldin & Deborah Salani. (2022) Calm Down With Kava: What Clinicians Need to Know. Journal of Psychosocial Nursing and Mental Health Services 60:12, pages 17-24.
Crossref
Crossref
Rafael Rocha da Silva Santos, Matheus Corrêa Ramos, Juliana Veloso Ferreira, José Eduardo Gonçalves & Isabela Costa César. (2022) Biopharmaceutical evaluation of kavain in Piper methysticum G. Forst dried extract: Equilibrium solubility and intestinal permeability in Caco-2 cell model. Journal of Ethnopharmacology 296, pages 115480.
Crossref
Crossref
Rita B. Soares, Ricardo Jorge Dinis-Oliveira & Nuno G. Oliveira. (2022) An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava. Journal of Clinical Medicine 11:14, pages 4039.
Crossref
Crossref
María Adelina Jiménez-Arellanes & Mariana Z. Pérez-González. 2022. Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications. Phenolic Compounds - Chemistry, Synthesis, Diversity, Non-Conventional Industrial, Pharmaceutical and Therapeutic Applications.
Yingli Wang, Chao Su, Bo Zhang, Yang Niu, Ruru Ren, Xiaojun Zhao, Lingling Yang, Wannian Zhang & Xueqin Ma. (2021) Biological Activity, Hepatotoxicity, and Structure-Activity Relationship of Kavalactones and Flavokavins, the Two Main Bioactive Components in Kava (Piper methysticum). Evidence-Based Complementary and Alternative Medicine 2021, pages 1-14.
Crossref
Crossref
Mariana Zuleima Pérez-González & María Adelina Jiménez-Arellanes. (2021) Biotechnological processes to obtain bioactive secondary metabolites from some Mexican medicinal plants. Applied Microbiology and Biotechnology 105:16-17, pages 6257-6274.
Crossref
Crossref
Ajay Srivastava & Prafulla Kumar. 2021. Nutraceuticals. Nutraceuticals
63
72
.
Tengfei Bian, Pedro Corral, Yuzhi Wang, Jordy Botello, Rick Kingston, Tyler Daniels, Ramzi G. Salloum, Edward Johnston, Zhiguang Huo, Junxuan Lu, Andrew C. Liu & Chengguo Xing. (2020) Kava as a Clinical Nutrient: Promises and Challenges. Nutrients 12:10, pages 3044.
Crossref
Crossref
Yijin Tang & Christine Fields. (2019) A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in Piper methysticum (Kava). Molecules 24:7, pages 1245.
Crossref
Crossref
C. Michael White. (2018) The Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava. The Journal of Clinical Pharmacology 58:11, pages 1396-1405.
Crossref
Crossref
Haruhiro Yamashita, Mark J. Hoenerhoff, Keith R. Shockley, Shyamal D. Peddada, Kevin E. Gerrish, Deloris Sutton, Connie A. Cummings, Yu Wang, Foley F. Julie, Mamta Behl, Suramya Waidyanatha, Robert C. Sills & Arun R. Pandiri. (2018) Reduced Disc Shedding and Phagocytosis of Photoreceptor Outer Segment Contributes to Kava Kava Extract–induced Retinal Degeneration in F344/N Rats. Toxicologic Pathology 46:5, pages 564-573.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
777
780
.
E. A. Davies & M. S. O'Mahony. (2015) Adverse drug reactions in special populations - the elderly. British Journal of Clinical Pharmacology 80:4, pages 796-807.
Crossref
Crossref
Iris Wainiqolo, Bridget Kool, Vili Nosa & Shanthi Ameratunga. (2015) Is driving under the influence of kava associated with motor vehicle crashes? A systematic review of the epidemiological literature. Australian and New Zealand Journal of Public Health 39:5, pages 495-499.
Crossref
Crossref
Dong Fu & Iqbal Ramzan. 2015. Phytotherapies. Phytotherapies
312
329
.
Raimo A. Ketola, Jenni Viinamäki, Ilpo Rasanen, Anna Pelander & Sirkka Goebeler. (2015) Fatal kavalactone intoxication by suicidal intravenous injection. Forensic Science International 249, pages e7-e11.
Crossref
Crossref
Cydney E. McQueen & Katherine Kelly Orr. 2015. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 18th Edition. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 18th Edition.
Sarah Hannam, Michael Murray, Lucia Romani, Meciusela Tuicakau & Margot J Whitfeld. (2014) Kava dermopathy in Fiji: an acquired ichthyosis?. International Journal of Dermatology 53:12, pages 1490-1494.
Crossref
Crossref
Simona Rossi & Victor J. Navarro. (2014) Herbs and Liver Injury: A Clinical Perspective. Clinical Gastroenterology and Hepatology 12:7, pages 1069-1076.
Crossref
Crossref
L.R. Olsen & C. Skonberg. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology
741
745
.
L.R. Olsen & C Skonberg. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology
13
16
.
Paul Posadzki, Leala Watson & Edzard Ernst. (2013) Herb–drug interactions: an overview of systematic reviews. British Journal of Clinical Pharmacology 75:3, pages 603-618.
Crossref
Crossref
Paul Posadzki, Leala K Watson & Edzard Ernst. (2013) Adverse effects of herbal medicines: an overview of systematic reviews. Clinical Medicine 13:1, pages 7-12.
Crossref
Crossref
Anthony Rowe & Iqbal Ramzan. (2012) Are Mould Hepatotoxins Responsible for Kava Hepatotoxicity?. Phytotherapy Research 26:11, pages 1768-1770.
Crossref
Crossref
Alexander V. LyubimovBill Gurley, Kim E. Fifer & Zöe Gardner. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
79
.
Karen Pilkington & Anelia Boshnakova. (2012) Complementary medicine and safety: A systematic investigation of design and reporting of systematic reviews. Complementary Therapies in Medicine 20:1-2, pages 73-82.
Crossref
Crossref
Rolf Teschke & Vincent Lebot. (2011) Proposal for a Kava Quality Standardization Code. Food and Chemical Toxicology 49:10, pages 2503-2516.
Crossref
Crossref
. (2011) Clinical Roundup: How Do You Treat Stress in Your Practice? Part 2. Alternative and Complementary Therapies 17:3, pages 181-187.
Crossref
Crossref
Anthony Rowe, Lillian Yuan Zhang & Iqbal Ramzan. (2011) Toxicokinetics of Kava. Advances in Pharmacological Sciences 2011, pages 1-6.
Crossref
Crossref
. 2011. A Guide to Evidence-based Integrative and Complementary Medicine. A Guide to Evidence-based Integrative and Complementary Medicine
855
875
.
Rolf Teschke. (2010) Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver International 30:9, pages 1270-1279.
Crossref
Crossref
X. Z. Li & I. Ramzan. (2009) Role of ethanol in kava hepatotoxicity. Phytotherapy Research 24:4, pages 475-480.
Crossref
Crossref
J. Sarris, D.J. Kavanagh, J. Adams, K. Bone & G. Byrne. (2009) Kava Anxiety Depression Spectrum Study (KADSS): A mixed methods RCT using an aqueous extract of Piper methysticum. Complementary Therapies in Medicine 17:3, pages 176-178.
Crossref
Crossref
. 2009. Meyler's Side Effects of Herbal Medicines. Meyler's Side Effects of Herbal Medicines
31
235
.
. 2009. MeylerâÂÂs Side Effects of Cardiovascular Drugs. MeylerâÂÂs Side Effects of Cardiovascular Drugs
557
820
.
Lingtak-Neander Chan. 2010. Handbook of Drug-Nutrient Interactions. Handbook of Drug-Nutrient Interactions
341
366
.
Donald G. Barceloux. 2008. Medical Toxicology of Natural Substances. Medical Toxicology of Natural Substances
525
531
.
B J Gurley, A Swain, M A Hubbard, F Hartsfield, J Thaden, D K Williams, W B Gentry & Y Tong. (2007) Supplementation With Goldenseal (Hydrastis canadensis), but not Kava Kava (Piper methysticum), Inhibits Human CYP3A Activity In Vivo. Clinical Pharmacology & Therapeutics 83:1, pages 61-69.
Crossref
Crossref
M.H. Pittler & E. Ernst. 2008. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions
551
560
.
Leonard B. Seeff. (2007) Herbal Hepatotoxicity. Clinics in Liver Disease 11:3, pages 577-596.
Crossref
Crossref
Stacie E. Geller & Laura Studee. (2007) Botanical and dietary supplements for mood and anxiety in menopausal women. Menopause 14:3, pages 541-549.
Crossref
Crossref
Bill J. Gurley, Ashley Swain, Gary W. Barone, D. Keith Williams, Philip Breen, C. Ryan Yates, Leslie B. Stuart, Martha A. Hubbard, Yudong Tong & Sreekhar Cheboyina. (2007)
Effect of Goldenseal (
Hydrastis canadensis
) and Kava Kava (
Piper methysticum
) Supplementation on Digoxin Pharmacokinetics in Humans
. Drug Metabolism and Disposition 35:2, pages 240-245.
Crossref
Crossref
Natasha P. Clayton, Katsuhiko Yoshizawa, Grace E. Kissling, Leo T. Burka, Po-Chuen Chan & Abraham Nyska. (2007) Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract. Experimental and Toxicologic Pathology 58:4, pages 223-236.
Crossref
Crossref
Vikas Kumar. (2006) Potential medicinal plants for CNS disorders: an overview. Phytotherapy Research 20:12, pages 1023-1035.
Crossref
Crossref
. 2006. Fitoterapia. Fitoterapia
319
368
.